CD4 and inflammatory bowel disease: Although patients with HIV, RA, IBD, and psoriasis did not have significantly higher risk for CHD compared with non-CID controls in the overall groups, the risk of MI was 2-fold higher in patients with HIV and RA with markers of advanced immune dysregulation (lower CD4 count for HIV) and inflammation (CRP for RA).